Great Point Partners LLC Acadia Pharmaceuticals Inc Transaction History

Great Point Partners LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $6.04 Million - $8.53 Million	-311,217 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $10.2 Million - $22.5 Million	-409,285 Reduced 56.81%	311,217 $8.03 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $49.3 Million - $68.2 Million	-1,201,061 Reduced 62.5%	720,502 $38.5 Million
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $4.25 Million - $6.64 Million	116,570 Added 6.46%	1,921,563 $79.3 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $7.49 Million - $10.1 Million	-190,754 Reduced 9.56%	1,804,993 $87.5 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $23.6 Million - $35 Million	745,747 Added 59.66%	1,995,747 $84.3 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $34.1 Million - $48.4 Million	-940,742 Reduced 42.94%	1,250,000 $53.5 Million
Q3 2019 Nov 15, 2019	BUY	$22.22 - $44.01 $15.3 Million - $30.4 Million	690,742 Added 46.05%	2,190,742 $78.8 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $11.7 Million - $14.1 Million	-500,000 Reduced 25.0%	1,500,000 $0
Q1 2019 May 14, 2019	SELL	$16.17 - $27.38 $12.2 Million - $20.6 Million	-752,256 Reduced 27.33%	2,000,000 $53.7 Million
Q4 2018 Feb 15, 2019	BUY	$14.32 - $22.92 $22.3 Million - $35.7 Million	1,556,158 Added 130.1%	2,752,256 $44.5 Million
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $10.5 Million - $17.5 Million	-803,902 Reduced 40.2%	1,196,098 $24.8 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $30.1 Million - $44.7 Million	2,000,000 New	2,000,000 $30.5 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.73B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.